Oncosec medical inc (ONCS)
Income statement / Yearly
Jul'19Jul'18Jul'17Jul'16Jul'15Jul'14Jul'13Jul'12Jul'11
Revenue

-

-

0

0

0

-

-

-

-

Expenses:
Research and development

18,445

17,415

11,952

14,741

13,132

5,796

3,159

2,368

648

General and administrative

11,971

18,689

9,669

12,144

8,108

6,153

3,905

3,158

1,047

Loss from operations

-30,416

-36,105

-21,622

-

-21,241

-11,949

-7,064

-5,527

-1,695

Other income, net

440

374

173

-

-

-

-

-

-

Fair value of derivative liabilities in excess of proceeds

-

-

-

-

-

-

-

-

-808

Adjustments to fair value of derivative liabilities

-

-

-

-

-

-

-

4,192

-

Adjustments to fair value of derivative liabilities

-

-

-

-

-

-

-

-

-1,041

Loss on extinguishment of debt

-

-

-

-

-

-

-

761

-

Financing transaction costs

-

-

-

-

-

-

-

-

210

Non-cash interest expense

-

-

-

-

-

20

83

266

-

Interest expense

3

-

-

-

-

-

-

-

1

Loss on disposal of property and equipment

-0

-875

0

-

-

-

-

-

-

Warrant inducement expense

-

2,465

0

-

-

-

-

-

-

Foreign currency exchange (loss) gain, net

-281

-63

-

-

-

-

-

-

-

Realized loss on sale of securities, net

-12

-

-

-

-

-

-

-

-

Loss before income taxes

-30,274

-39,135

-21,448

-26,886

-

-

-

-

-

Net loss before income taxes

-

-

-

-

-

-11,970

-7,148

-2,362

-3,757

Provision for income taxes

1

0

1

2

1

41

2

2

1

Net loss

-30,276

-39,136

-21,449

-26,888

-21,243

-

-

-

-

Basic and diluted net loss per common share

-4.29

-9.75

-1.06

-1.63

-1.67

-1.26

-1.34

-0.04

-

Weighted average shares used in computing basic and diluted net loss per common share

7,053

4,012

20,189

16,514

12,708

9,527

5,327

67,443

-

Net loss

-

-

-

-

-

-12,012

-7,150

-2,364

-3,758

Basic net loss per common share

-

-

-

-

-

-

-

-

-0.06

Diluted net loss per common share

-

-

-

-

-

-

-

-

-0.06

Weighted average shares used in computing basic net loss per common share

-

-

-

-

-

-

-

-

63,300

Weighted average shares used in computing diluted net loss per common share

-

-

-

-

-

-

-

-

63,300